Literature DB >> 31647982

The macro-metastasis/organ parenchyma interface (MMPI) - A hitherto unnoticed area.

R Blazquez1, D Sparrer1, C Wendl2, M Evert3, M J Riemenschneider4, M P Krahn5, N Erez6, M Proescholdt7, T Pukrop8.   

Abstract

The macro-metastasis/organ parenchyma interface (MMPI) was previously considered an inert anatomical border which sharply separates the affected organ parenchyma from the macro-metastatic tissue. Recently, infiltrative growth of macro-metastases from various primary tumors was described in the brain, liver and lung, with significant impact on survival. Strikingly, the MMPI patterns differed between entities, so that at least nine different patterns were described. The MMPI patterns could be further classified into three major groups: displacing, epithelial and diffuse infiltrating. Additionally, macro-metastases are a source of further tumor cell dissemination in the affected organ; and these intra-organ metastatic dissemination tracks starting from the MMPI also vary depending on the anatomical structures of the colonized organ and influence disease outcome. In spite of their relevance, MMPIs and organ-specific dissemination tracks are still largely overlooked by many clinicians, pathologists and/or researchers. In this review, we aim to address this important issue and enhance our current understanding of the different MMPI patterns and dissemination tracks in the brain, liver and lung.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Displacing; Dissemination; Infiltration; Interface; Macro-metastasis

Mesh:

Year:  2019        PMID: 31647982     DOI: 10.1016/j.semcancer.2019.10.012

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  3 in total

1.  Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain.

Authors:  Raquel Blazquez; Han-Ning Chuang; Britta Wenske; Laura Trigueros; Darius Wlochowitz; Renato Liguori; Fulvia Ferrazzi; Tommy Regen; Martin A Proescholdt; Veit Rohde; Markus J Riemenschneider; Christine Stadelmann; Annalen Bleckmann; Tim Beißbarth; Denise van Rossum; Uwe K Hanisch; Tobias Pukrop
Journal:  Oncogene       Date:  2022-10-12       Impact factor: 8.756

2.  Impact of pre-OP independence in patients with limited brain metastases on long-term survival.

Authors:  Annalen Bleckmann; Benjamin Kirchner; Manuel Nietert; Micha Peeck; Marko Balkenhol; Daniela Egert; T Veit Rohde; Tim Beißbarth; Tobias Pukrop
Journal:  BMC Cancer       Date:  2020-10-08       Impact factor: 4.430

3.  Breakouts-A Radiological Sign of Poor Prognosis in Patients With Brain Metastases.

Authors:  Raquel Blazquez; Martin Andreas Proescholdt; Marlene Klauser; Karl-Michael Schebesch; Christian Doenitz; Daniel Heudobler; Lena Stange; Markus J Riemenschneider; Elisabeth Bumes; Katharina Rosengarth; Andreas Schicho; Nils-Ole Schmidt; Alexander Brawanski; Tobias Pukrop; Christina Wendl
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.